NCT00749359View on ClinicalTrials.gov

PAXIL CR Bioequivalence Study

PHASE1CompletedINTERVENTIONAL

Enrollment

166

Participants

Timeline

Start Date

July 7, 2008

Primary Completion Date

September 16, 2008

Study Completion Date

September 16, 2008

Conditions

Depressive Disorder

Interventions

DRUG

Paxil CR

Paxil CR 37mg tablet manufactures at two different sites

Trial Locations (2)

14202

GSK Investigational Site, Buffalo

98418

GSK Investigational Site, Tacoma

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY